Back to today’s briefing

Story perspectives

FDA Approves Tryptyr: Revolutionary Solution for Dry Eyes

5/30/2025

32 6

Summary

Story summary

Alcon Inc.'s groundbreaking ophthalmic solution, Tryptyr, has gained FDA approval to combat dry eye disease. In clinical trials involving over 930 patients, it demonstrated remarkable improvements in natural tear production within just two weeks. By stimulating corneal nerves, Tryptyr boosts tear output and will hit the US market in single-dose vials by Q3 2025.

1 of 1

Story summary

Alcon Inc.'s groundbreaking ophthalmic solution, Tryptyr, has gained FDA approval to combat dry eye disease. In clinical trials involving over 930 patients, it demonstrated remarkable improvements in natural tear production within just two weeks. By stimulating corneal nerves, Tryptyr boosts tear output and will hit the US market in single-dose vials by Q3 2025.